Magnetically Controlled Growing Rods Graduation: Lessons From a Single-center Series of 48 Patients

J Pediatr Orthop. 2024 Feb 1;44(2):e157-e162. doi: 10.1097/BPO.0000000000002560. Epub 2023 Nov 6.

Abstract

Background: Magnetically controlled growing rod (MCGR) treatment for early-onset scoliosis (EOS) has become a widely utilized method of deformity control, but long-term follow-up reports are sparse. We evaluated the outcomes of a large group of consecutive pediatric patients diagnosed with EOS who were treated by MCGR to the endpoint of definitive spinal fusion in a single center. We hypothesized that lessons learned from treating a large volume of MCGR patients would lower the complication rate in comparison to what was previously reported by other studies.

Methods: The records of 48 EOS patients with varied etiologies who were treated by MCGR between 2012 and 2022 and reached the end of treatment were analyzed retrospectively for baseline and final radiographic measurements and surgery-related complications.

Results: The mean percent of improvement in the major coronal deformity was 51.7±25.0% and the mean T1 to T12 total growth was 52.9±21.9 mm. The total complication rate was 22.9% of which 12.5% required a single unplanned surgery, 6.3% required multiple unplanned surgeries, and 4% did not require any unplanned surgery.

Conclusion: MCGR treatment provides adequate control of EOS, enabling satisfactory growth of the thoracic spine. The complication rate in a single large volume center is moderate.

Level of evidence: IV.

MeSH terms

  • Child
  • Follow-Up Studies
  • Humans
  • Magnets
  • Retrospective Studies
  • Scoliosis* / diagnostic imaging
  • Scoliosis* / surgery
  • Spinal Fusion*
  • Spine / surgery
  • Treatment Outcome